Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
Author:
Funder
Cancer Clinical Research Trust
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/1/68/13783551/mdq349.pdf
Reference23 articles.
1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
3. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc Natl Acad Sci USA,1992
4. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease;Cobleigh;J Clin Oncol,1999
5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Highlights of current and future for the treatment of resistant HER2+ breast cancer to HER2-targeted therapies;Overcoming Cancers Resistant to HER-2 Antibodies;2024
2. Resistance of HER2-expressing ovarian cancer to trastuzumab and mechanisms of overcoming resistance;Overcoming Cancers Resistant to HER-2 Antibodies;2024
3. AXL – a new player in resistance to HER2 blockade;Cancer Treatment Reviews;2023-12
4. Development of covalent inhibitors: Principle, design, and application in cancer;MedComm – Oncology;2023-10-31
5. Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies;Cancers;2023-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3